lilly retatrutide trial Retatrutide, Eli Lilly's next obesity drug, fueled dramatic weight loss in clinical How to Get Retatrutide in

We are the leaders in weight loss and prevention of lifestyle diseases

Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells

While nobody can say for sure what the future of microdosing GLP-1s holds, Midi is dedicated to staying updated on the best practices as evidence emerges

The GLP-1 Bridge program will cover three drugs, Foundayo, Wegovy and Zepbound, and be available to people who have Medicare Part D, an optional extra coverage to lower the cost of prescriptions

DOI: 10.2337/db10-0474 Shaefer CF Jr et al (2015): User's guide to mechanism of action and clinical use of GLP-1 receptor agonists

doi: Mennella I, Fogliano V, Ferracane R, Arlorio M, Pattarino F, Vitaglione P